Title: The Influence of CYP3A5 Genotype on Dexamethasone Induction of CYP3A Activity in

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation

  2008cited by this paper
• CYP3A5 Genotype has an Impact on the Metabolism of the HIV Protease Inhibitor Saquinavir

  2007cited by this paper
• Cytochrome P450 3A5 Genotype is Associated with Verapamil Response in Healthy Subjects

  2007cited by this paper
• CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population

  2006cited by this paper
• Pharmacogenetic Characteristics of Indinavir, Zidovudine, and Lamivudine Therapy in HIV-Infected Adults: A Pilot Study

  2006cited by this paper
• Sequence diversity and haplotype structure at the human CYP3A cluster

  2006cited by this paper
• Low hepatic cytochrome P450 3A activity is a risk for corticosteroid‐induced osteonecrosis

  2006cited by this paper
• Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5

  2005cited by this paper
• A Novel Polymorphic Cytochrome P450 Formed by Splicing of CYP3A7 and the Pseudogene CYP3AP1*

  2005cited by this paper
• CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS

  2005cited by this paper
• Drug metabolism and variability among patients in drug response.

  2005cited by this paper
• Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states

  2004cited by this paper
• CYP3A5 Genotype and Midazolam Clearance in Australian Patients Receiving Chemotherapy

  2004cited by this paper
• The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients.

  2004cited by this paper
• Genetics of the variable expression of CYP3A in humans.

  2004cited by this paper
• The Induction of Cytochrome P450 3A5 (CYP3A5) in the Human Liver and Intestine Is Mediated by the Xenobiotic Sensors Pregnane X Receptor (PXR) and Constitutively Activated Receptor (CAR)*

  2004cited by this paper
• Cytochrome P450 3A and their regulation

  2004cited by this paper
• Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokinetics.

  2004cited by this paper
• Genetic variability in CYP3A5 and its possible consequences.

  2004cited by this paper
• Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR‐1, CYP3A4, and CYP3A5 genes

  2004cited by this paper
• Impact of cytochrome P450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients12

  2003cited by this paper
• Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women.

  2003cited by this paper
• Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR‐1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

  2003cited by this paper
• Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man

  2002cited by this paper
• Genetic contribution to variable human CYP3A-mediated metabolism.

  2002cited by this paper
• Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism.

  2002cited by this paper
• Regulation of cyp3a gene transcription by the pregnane x receptor.

  2002cited by this paper
• Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

  2001cited by this paper
• Primary porcine enterocyte and hepatocyte cultures to study drug oxidation reactions

  2000cited by this paper
• In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone

  2000cited by this paper
• Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A

  1999cited by this paper
• Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.

  1998cited by this paper
• The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.

  1998cited by this paper
• Effect of Multiple Doses of Rifampin on the [14C N‐methyl] Erythromycin Breath Test in Healthy Male Volunteers

  1998cited by this paper
• Comparison of urinary 6‐β‐cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity

  1992cited by this paper
• Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).

  1990cited by this paper
• Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients.

  1989cited by this paper

• No citing papers are available for this paper.